메뉴 건너뛰기




Volumn 2, Issue 6, 2009, Pages 673-683

Advancements in gene transfer-based therapy for hemophilia A

Author keywords

Adeno associated virus; Adenovirus; Factor VIII; Gene therapy; Hematopoietic stem cell transplantation; Hemophilia A; Lentivirus; Oncoretrovirus; Transposon; Viral vector

Indexed keywords

BLOOD CLOTTING FACTOR 8; COMPLEMENTARY DNA;

EID: 77953443194     PISSN: 17474086     EISSN: None     Source Type: Journal    
DOI: 10.1586/ehm.09.63     Document Type: Review
Times cited : (13)

References (95)
  • 1
    • 0038101450 scopus 로고    scopus 로고
    • Haemophilias A and B
    • Bolton-Maggs PH, Pasi KJ. Haemophilias A and B. Lancet 361(9371), 1801-1809 (2003).
    • (2003) Lancet , vol.361 , Issue.9371 , pp. 1801-1809
    • Bolton-Maggs, P.H.1    Pasi, K.J.2
  • 2
    • 0021750055 scopus 로고
    • Characterization of the human factor VIII gene
    • Gitschier J, Wood WI, Goralka TM et al. Characterization of the human factor VIII gene. Nature 312(5992), 326-330 (1984).
    • (1984) Nature , vol.312 , Issue.5992 , pp. 326-330
    • Gitschier, J.1    Wood, W.I.2    Goralka, T.M.3
  • 3
    • 0021715169 scopus 로고
    • Molecular cloning of a cDNA encoding human antihaemophilic factor
    • Toole JJ, Knopf JL, Wozney JM et al. Molecular cloning of a cDNA encoding human antihaemophilic factor. Nature 312(5992), 342-347 (1984).
    • (1984) Nature , vol.312 , Issue.5992 , pp. 342-347
    • Toole, J.J.1    Knopf, J.L.2    Wozney, J.M.3
  • 4
    • 1942521325 scopus 로고    scopus 로고
    • Bioengineering of coagulation factor VIII for improved secretion
    • Miao HZ, Sirachainan N, Palmer L et al. Bioengineering of coagulation factor VIII for improved secretion. Blood 103(9), 3412-3419 (2004).
    • (2004) Blood , vol.103 , Issue.9 , pp. 3412-3419
    • Miao, H.Z.1    Sirachainan, N.2    Palmer, L.3
  • 5
    • 0020582124 scopus 로고
    • Construction of a retrovirus packaging mutant and its use to produce helper-free defective retrovirus
    • Mann R, Mulligan RC, Baltimore D. Construction of a retrovirus packaging mutant and its use to produce helper-free defective retrovirus. Cell 33(1), 153-159 (1983).
    • (1983) Cell , vol.33 , Issue.1 , pp. 153-159
    • Mann, R.1    Mulligan, R.C.2    Baltimore, D.3
  • 6
    • 0025257348 scopus 로고
    • Retroviralmediated transfer and amplification of a functional human factor VIII gene
    • Israel DI, Kaufman RJ. Retroviralmediated transfer and amplification of a functional human factor VIII gene. Blood 75(5), 1074-1080 (1990).
    • (1990) Blood , vol.75 , Issue.5 , pp. 1074-1080
    • Israel, D.I.1    Kaufman, R.J.2
  • 8
    • 0142084745 scopus 로고    scopus 로고
    • LMO2-associated clonal T-cell proliferation in two patients after gene therapy for SCID-X1
    • Hacein-Bey-Abina S, Von Kalle C, Schmidt M et al. LMO2-associated clonal T-cell proliferation in two patients after gene therapy for SCID-X1. Science 302(5644), 415-419 (2003).
    • (2003) Science , vol.302 , Issue.5644 , pp. 415-419
    • Hacein-Bey-Abina, S.1    Von Kalle, C.2    Schmidt, M.3
  • 9
    • 51349158298 scopus 로고    scopus 로고
    • Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patients
    • Howe SJ, Mansour MR, Schwarzwaelder K et al. Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patients. J. Clin. Invest. 118(9), 3143-3150 (2008).
    • (2008) J. Clin. Invest. , vol.118 , Issue.9 , pp. 3143-3150
    • Howe, S.J.1    Mansour, M.R.2    Schwarzwaelder, K.3
  • 10
    • 0028842288 scopus 로고
    • Gene therapy for hemophilia A: Production of therapeutic levels of human factor VIII in vivo in mice
    • Dwarki VJ, Belloni P, Nijjar T et al. Gene therapy for hemophilia A: production of therapeutic levels of human factor VIII in vivo in mice. Proc. Natl Acad. Sci. USA 92(4), 1023-1027 (1995).
    • (1995) Proc. Natl Acad. Sci. USA , vol.92 , Issue.4 , pp. 1023-1027
    • Dwarki, V.J.1    Belloni, P.2    Nijjar, T.3
  • 11
    • 0032510756 scopus 로고    scopus 로고
    • Genetic induction of immune tolerance to human clotting factor VIII in a mouse model for hemophilia A
    • Evans GL, Morgan RA. Genetic induction of immune tolerance to human clotting factor VIII in a mouse model for hemophilia A. Proc Natl Acad. Sci. USA, 95(10), 5734-5739 (1998).
    • (1998) Proc Natl Acad. Sci. USA , vol.95 , Issue.10 , pp. 5734-5739
    • Evans, G.L.1    Morgan, R.A.2
  • 12
    • 0026534020 scopus 로고
    • Toward gene therapy in haemophilia A: Retrovirus-mediated transfer of a factor VIII gene into murine haematopoietic progenitor cells
    • Hoeben RC, Einerhand MP, Briet E, van Ormondt H, Valerio D, Van Der Eb AJ. Toward gene therapy in haemophilia A: retrovirus-mediated transfer of a factor VIII gene into murine haematopoietic progenitor cells. Thromb. Haemost. 67(3), 341-345 (1992).
    • (1992) Thromb. Haemost. , vol.67 , Issue.3 , pp. 341-345
    • Hoeben, R.C.1    Einerhand, M.P.2    Briet, E.3    Van Ormondt, H.4    Valerio, D.5    Van Der Eb, A.J.6
  • 13
    • 0141962306 scopus 로고    scopus 로고
    • Recombinant factor VIII expression in hematopoietic cells following lentiviral transduction
    • Tiede A, Eder M, von Depka M et al. Recombinant factor VIII expression in hematopoietic cells following lentiviral transduction. Gene Ther. 10(22), 1917-1925 (2003).
    • (2003) Gene Ther. , vol.10 , Issue.22 , pp. 1917-1925
    • Tiede, A.1    Eder, M.2    Von Depka, M.3
  • 14
    • 0036330685 scopus 로고    scopus 로고
    • Generation and characterization of human hematopoietic cell lines expressing factor VIII. J. Hematother
    • Tonn T, Herder C, Becker S, Seifried E, Grez M. Generation and characterization of human hematopoietic cell lines expressing factor VIII. J. Hematother. Stem Cell Res. 11(4), 695-704 (2002).
    • (2002) Stem Cell Res. , vol.11 , Issue.4 , pp. 695-704
    • Tonn, T.1    Herder, C.2    Becker, S.3    Seifried, E.4    Grez, M.5
  • 15
    • 0034689505 scopus 로고    scopus 로고
    • Long-term persistence of human bone marrow stromal cells transduced with factor VIII-retroviral vectors and transient production of therapeutic levels of human factor VIII in nonmyeloablated immunodeficient mice
    • Chuah MK, Van Damme A, Zwinnen H et al. Long-term persistence of human bone marrow stromal cells transduced with factor VIII-retroviral vectors and transient production of therapeutic levels of human factor VIII in nonmyeloablated immunodeficient mice. Hum. Gene Ther. 11(5), 729-738 (2000).
    • (2000) Hum. Gene Ther. , vol.11 , Issue.5 , pp. 729-738
    • Chuah, M.K.1    Van Damme, A.2    Zwinnen, H.3
  • 16
    • 0032080179 scopus 로고    scopus 로고
    • Sustained phenotypic correction of murine hemophilia A by in vivo gene therapy
    • Connelly S, Andrews JL, Gallo AM et al. Sustained phenotypic correction of murine hemophilia A by in vivo gene therapy. Blood 91(9), 3273-3281 (1998).
    • (1998) Blood , vol.91 , Issue.9 , pp. 3273-3281
    • Connelly, S.1    Andrews, J.L.2    Gallo, A.M.3
  • 17
    • 0029943193 scopus 로고    scopus 로고
    • Sustained expression of therapeutic levels of human factor VIII in mice
    • Connelly S, Gardner JM, Lyons RM, McClelland A, Kaleko M. Sustained expression of therapeutic levels of human factor VIII in mice. Blood 87(11), 4671-4677 (1996). (Pubitemid 26162366)
    • (1996) Blood , vol.87 , Issue.11 , pp. 4671-4677
    • Connelly, S.1    Gardner, J.M.2    Lyons, R.M.3    McClelland, A.4    Kaleko, M.5
  • 18
    • 0030069229 scopus 로고    scopus 로고
    • High-level tissue-specific expression of functional human factor VIII in mice
    • Connelly S, Gardner JM, McClelland A, Kaleko M. High-level tissue-specific expression of functional human factor VIII in mice. Hum. Gene Ther. %20;7(2), 183-195 (1996). (Pubitemid 26044837)
    • (1996) Human Gene Therapy , vol.7 , Issue.2 , pp. 183-195
    • Connelly, S.1    Gardner, J.M.2    McClelland, A.3    Kaleko, M.4
  • 19
    • 0028991820 scopus 로고
    • In vivo gene delivery and expression of physiological levels of functional human factor VIII in mice
    • Connelly S, Smith TA, Dhir G et al. In vivo gene delivery and expression of physiological levels of functional human factor VIII in mice. Hum. Gene Ther. 6(2), 185-193 (1995).
    • (1995) Hum. Gene Ther. , vol.6 , Issue.2 , pp. 185-193
    • Connelly, S.1    Smith, T.A.2    Dhir, G.3
  • 20
    • 0033587552 scopus 로고    scopus 로고
    • In vivo evaluation of an adenoviral vector encoding canine factor VIII: High-level, sustained expression in hemophiliac mice
    • Gallo-Penn AM, Shirley PS, Andrews JL et al. In vivo evaluation of an adenoviral vector encoding canine factor VIII: high-level, sustained expression in hemophiliac mice. Hum. Gene Ther. 10(11), 1791 - 1802 (1999).
    • (1999) Hum. Gene Ther. , vol.10 , Issue.11 , pp. 1791-1802
    • Gallo-Penn, A.M.1    Shirley, P.S.2    Andrews, J.L.3
  • 21
    • 0035174331 scopus 로고    scopus 로고
    • Systemic delivery of an adenoviral vector encoding canine factor VIII results in short-term phenotypic correction, inhibitor development, and biphasic liver toxicity in hemophilia A dogs
    • Gallo-Penn AM, Shirley PS, Andrews JL et al. Systemic delivery of an adenoviral vector encoding canine factor VIII results in short-term phenotypic correction, inhibitor development, and biphasic liver toxicity in hemophilia A dogs. Blood 97(1), 107-113 (2001).
    • (2001) Blood , vol.97 , Issue.1 , pp. 107-113
    • Gallo-Penn, A.M.1    Shirley, P.S.2    Andrews, J.L.3
  • 22
    • 0036377825 scopus 로고    scopus 로고
    • Evaluation of the duration of human factor VIII expression in nonhuman primates after systemic delivery of an adenoviral vector
    • Andrews JL, Shirley PS, Iverson WO et al. Evaluation of the duration of human factor VIII expression in nonhuman primates after systemic delivery of an adenoviral vector. Hum. Gene Ther. 13(11), 1331-1336 (2002).
    • (2002) Hum. Gene Ther. , vol.13 , Issue.11 , pp. 1331-1336
    • Andrews, J.L.1    Shirley, P.S.2    Iverson, W.O.3
  • 23
    • 0033544952 scopus 로고    scopus 로고
    • Adenoviral vector-mediated expression of physiologic levels of human factor VIII in nonhuman primates
    • Brann T, Kayda D, Lyons RM et al. Adenoviral vector-mediated expression of physiologic levels of human factor VIII in nonhuman primates. Hum. Gene Ther. 10(18), 2999-3011 (1999).
    • (1999) Hum. Gene Ther. , vol.10 , Issue.18 , pp. 2999-3011
    • Brann, T.1    Kayda, D.2    Lyons, R.M.3
  • 24
    • 0029943155 scopus 로고    scopus 로고
    • A new adenoviral vector: Replacement of all viral coding sequences with 28 kb of DNA independently expressing both full-length dystrophin and b-galactosidase
    • Kochanek S, Clemens PR, Mitani K, Chen HH, Chan S, Caskey CT. A new adenoviral vector: replacement of all viral coding sequences with 28 kb of DNA independently expressing both full-length dystrophin and b-galactosidase. Proc. Natl Acad. Sci. USA 93(12), 5731-5736 (1996).
    • (1996) Proc. Natl Acad. Sci. USA , vol.93 , Issue.12 , pp. 5731-5736
    • Kochanek, S.1    Clemens, P.R.2    Mitani, K.3    Chen, H.H.4    Chan, S.5    Caskey, C.T.6
  • 25
    • 0031916435 scopus 로고    scopus 로고
    • Genomic DNA transfer with a highcapacity adenovirus vector results in improved in vivo gene expression and decreased toxicity
    • Schiedner G, Morral N, Parks RJ et al. Genomic DNA transfer with a highcapacity adenovirus vector results in improved in vivo gene expression and decreased toxicity. Nat. Genet. 18(2), 180-183 (1998).
    • (1998) Nat. Genet. , vol.18 , Issue.2 , pp. 180-183
    • Schiedner, G.1    Morral, N.2    Parks, R.J.3
  • 26
    • 13044304200 scopus 로고    scopus 로고
    • Administration of helper-dependent adenoviral vectors and sequential delivery of different vector serotype for long-term liver-directed gene transfer in baboons
    • Morral N, O'Neal W, Rice K et al. Administration of helper-dependent adenoviral vectors and sequential delivery of different vector serotype for long-term liver-directed gene transfer in baboons. Proc. Natl Acad. Sci. USA 96(22), 12816-12821 (1999).
    • (1999) Proc. Natl Acad. Sci. USA , vol.96 , Issue.22 , pp. 12816-12821
    • Morral, N.1    O'Neal, W.2    Rice, K.3
  • 27
    • 0037372398 scopus 로고    scopus 로고
    • Therapeutic factor VIII levels and negligible toxicity in mouse and dog models of hemophilia A following gene therapy with high-capacity adenoviral vectors
    • Chuah MK, Schiedner G, Thorrez L et al. Therapeutic factor VIII levels and negligible toxicity in mouse and dog models of hemophilia A following gene therapy with high-capacity adenoviral vectors. Blood 101(5), 1734-1743 (2003).
    • (2003) Blood , vol.101 , Issue.5 , pp. 1734-1743
    • Chuah, M.K.1    Schiedner, G.2    Thorrez, L.3
  • 28
    • 0036154968 scopus 로고    scopus 로고
    • Sustained human factor VIII expression in hemophilia A mice following systemic delivery of a gutless adenoviral vector
    • Reddy PS, Sakhuja K, Ganesh S et al. Sustained human factor VIII expression in hemophilia A mice following systemic delivery of a gutless adenoviral vector. Mol. Ther. 5(1), 63-73 (2002).
    • (2002) Mol. Ther. , vol.5 , Issue.1 , pp. 63-73
    • Reddy, P.S.1    Sakhuja, K.2    Ganesh, S.3
  • 29
    • 12944317288 scopus 로고    scopus 로고
    • Sustained high-level expression of full-length human factor VIII and restoration of clotting activity in hemophilic mice using a minimal adenovirus vector
    • Balague C, Zhou J, Dai Y et al. Sustained high-level expression of full-length human factor VIII and restoration of clotting activity in hemophilic mice using a minimal adenovirus vector. Blood 95(3), 820-828 (2000).
    • (2000) Blood , vol.95 , Issue.3 , pp. 820-828
    • Balague, C.1    Zhou, J.2    Dai, Y.3
  • 30
    • 0032718034 scopus 로고    scopus 로고
    • Development and application of a minimal-adenoviral vector system for gene therapy of hemophilia A
    • Zhang WW, Josephs SF, Zhou J et al. Development and application of a minimal-adenoviral vector system for gene therapy of hemophilia A. Thromb. Haemost. 82(2), 562-571 (1999).
    • (1999) Thromb. Haemost. , vol.82 , Issue.2 , pp. 562-571
    • Zhang, W.W.1    Josephs, S.F.2    Zhou, J.3
  • 31
    • 2342461788 scopus 로고    scopus 로고
    • Preclinical gene therapy studies for hemophilia using adenoviral vectors
    • Thorrez L, Vanden Driessche T, Collen D, Chuah MK. Preclinical gene therapy studies for hemophilia using adenoviral vectors. Semin. Thromb. Hemost. 30(2), 173-183 (2004).
    • (2004) Semin. Thromb. Hemost. , vol.30 , Issue.2 , pp. 173-183
    • Thorrez, L.1    Vanden Driessche, T.2    Collen, D.3    Chuah, M.K.4
  • 32
    • 0035822005 scopus 로고    scopus 로고
    • Nonviral transfer of the gene encoding coagulation factor VIII in patients with severe hemophilia A
    • Roth DA, Tawa NE Jr, O'Brien JM, Treco DA, Selden RF. Nonviral transfer of the gene encoding coagulation factor VIII in patients with severe hemophilia A. N. Engl. J. Med. 344(23), 1735-1742 (2001).
    • (2001) N. Engl. J. Med. , vol.344 , Issue.23 , pp. 1735-1742
    • Roth, D.A.1    Tawa Jr., N.E.2    O'Brien, J.M.3    Treco, D.A.4    Selden, R.F.5
  • 33
    • 0141679053 scopus 로고    scopus 로고
    • Phase 1 trial of fVIII gene transfer for severe hemophilia A using a retroviral construct administered by peripheral intravenous infusion
    • Powell JS, Ragni MV, White GC 2nd et al. Phase 1 trial of fVIII gene transfer for severe hemophilia A using a retroviral construct administered by peripheral intravenous infusion. Blood 102(6), 2038-2045 (2003).
    • (2003) Blood , vol.102 , Issue.6 , pp. 2038-2045
    • Powell, J.S.1    Ragni, M.V.2    White II, G.C.3
  • 34
    • 0032725333 scopus 로고    scopus 로고
    • Animal testing of retroviral-mediated gene therapy for factor VIII deficiency
    • Greengard JS, Jolly DJ. Animal testing of retroviral-mediated gene therapy for factor VIII deficiency. Thromb. Haemost. 82(2), 555-561 (1999).
    • (1999) Thromb. Haemost. , vol.82 , Issue.2 , pp. 555-561
    • Greengard, J.S.1    Jolly, D.J.2
  • 36
    • 0028917478 scopus 로고
    • Expression of the blood-clotting factor-VIII cDNA is repressed by a transcriptional silencer located in its coding region
    • Hoeben RC, Fallaux FJ, Cramer SJ et al. Expression of the blood-clotting factor-VIII cDNA is repressed by a transcriptional silencer located in its coding region. Blood 85(9), 2447-2454 (1995).
    • (1995) Blood , vol.85 , Issue.9 , pp. 2447-2454
    • Hoeben, R.C.1    Fallaux, F.J.2    Cramer, S.J.3
  • 37
    • 0029098922 scopus 로고
    • Sequences within the coding regions of clotting factor VIII and CFTR block transcriptional elongation
    • Koeberl DD, Halbert CL, Krumm A, Miller AD. Sequences within the coding regions of clotting factor VIII and CFTR block transcriptional elongation. Hum. Gene Ther. 6(4), 469-479 (1995).
    • (1995) Hum. Gene Ther. , vol.6 , Issue.4 , pp. 469-479
    • Koeberl, D.D.1    Halbert, C.L.2    Krumm, A.3    Miller, A.D.4
  • 38
    • 0032478644 scopus 로고    scopus 로고
    • Differential interaction of coagulation factor VIII and factor v with protein chaperones calnexin and calreticulin
    • Pipe SW, Morris JA, Shah J, Kaufman RJ. Differential interaction of coagulation factor VIII and factor V with protein chaperones calnexin and calreticulin. J. Biol. Chem. 273(14), 8537-8544 (1998).
    • (1998) J. Biol. Chem. , vol.273 , Issue.14 , pp. 8537-8544
    • Pipe, S.W.1    Morris, J.A.2    Shah, J.3    Kaufman, R.J.4
  • 39
    • 0023597393 scopus 로고
    • The relationship of N-linked glycosylation and heavy chain-binding protein association with the secretion of glycoproteins
    • Dorner AJ, Bole DG, Kaufman RJ. The relationship of N-linked glycosylation and heavy chain-binding protein association with the secretion of glycoproteins. J. Cell Biol. 105(6 Pt 1), 2665-2674 (1987).
    • (1987) J. Cell Biol. , vol.105 , Issue.6 PART 1 , pp. 2665-2674
    • Dorner, A.J.1    Bole, D.G.2    Kaufman, R.J.3
  • 40
    • 0035871099 scopus 로고    scopus 로고
    • The interaction of the calcium- and integrin-binding protein (cibp) with the coagulation factor VIII
    • Fang X, Chen C, Wang Q, Gu J, Chi C. The interaction of the calcium- and integrin-binding protein (cibp) with the coagulation factor VIII. Thromb. Res. 102(2), 177-185 (2001).
    • (2001) Thromb. Res. , vol.102 , Issue.2 , pp. 177-185
    • Fang, X.1    Chen, C.2    Wang, Q.3    Gu, J.4    Chi, C.5
  • 41
    • 0037336295 scopus 로고    scopus 로고
    • Quality control in the endoplasmic reticulum
    • Ellgaard L, Helenius A. Quality control in the endoplasmic reticulum. Nat. Rev. Mol. Cell. Biol. 4(3), 181-191 (2003).
    • (2003) Nat. Rev. Mol. Cell. Biol. , vol.4 , Issue.3 , pp. 181-191
    • Ellgaard, L.1    Helenius, A.2
  • 42
    • 0020595853 scopus 로고
    • Hepatoma secretory proteins migrate from rough endoplasmic reticulum to Golgi at characteristic rates
    • Lodish HF, Kong N, Snider M, Strous GJ. Hepatoma secretory proteins migrate from rough endoplasmic reticulum to Golgi at characteristic rates. Nature 304(5921), 80-83 (1983).
    • (1983) Nature , vol.304 , Issue.5921 , pp. 80-83
    • Lodish, H.F.1    Kong, N.2    Snider, M.3    Strous, G.J.4
  • 43
    • 0032478548 scopus 로고    scopus 로고
    • Mutations in the ER-golgi intermediate compartment protein ERGIC-53 cause combined deficiency of coagulation factors v and VIII
    • Nichols WC, Seligsohn U, Zivelin A et al. Mutations in the ER-golgi intermediate compartment protein ERGIC-53 cause combined deficiency of coagulation factors V and VIII. Cell 93(1), 61-70 (1998).
    • (1998) Cell , vol.93 , Issue.1 , pp. 61-70
    • Nichols, W.C.1    Seligsohn, U.2    Zivelin, A.3
  • 44
    • 0038278822 scopus 로고    scopus 로고
    • Bleeding due to disruption of a cargo-specific ER-to-Golgi transport complex
    • Zhang B, Cunningham MA, Nichols WC et al. Bleeding due to disruption of a cargo-specific ER-to-Golgi transport complex. Nat. Genet. 34(2), 220-225 (2003).
    • (2003) Nat. Genet. , vol.34 , Issue.2 , pp. 220-225
    • Zhang, B.1    Cunningham, M.A.2    Nichols, W.C.3
  • 45
    • 0032704952 scopus 로고    scopus 로고
    • Mannosedependent endoplasmic reticulum (ER)-Golgi intermediate compartment-53- mediated ER to Golgi trafficking of coagulation factors v and VIII
    • Moussalli M, Pipe SW, Hauri HP, Nichols WC, Ginsburg D, Kaufman RJ. Mannosedependent endoplasmic reticulum (ER)-Golgi intermediate compartment-53- mediated ER to Golgi trafficking of coagulation factors V and VIII. J. Biol. Chem. 274(46), 32539-32542 (1999).
    • (1999) J. Biol. Chem. , vol.274 , Issue.46 , pp. 32539-32542
    • Moussalli, M.1    Pipe, S.W.2    Hauri, H.P.3    Nichols, W.C.4    Ginsburg, D.5    Kaufman, R.J.6
  • 46
    • 1942430638 scopus 로고    scopus 로고
    • LMAN1 is a molecular chaperone for the secretion of coagulation factor VIII
    • Cunningham MA, Pipe SW, Zhang B et al. LMAN1 is a molecular chaperone for the secretion of coagulation factor VIII. J. Thromb. Haemost. 1(11), 2360-2367 (2003).
    • (2003) J. Thromb. Haemost. , vol.1 , Issue.11 , pp. 2360-2367
    • Cunningham, M.A.1    Pipe, S.W.2    Zhang, B.3
  • 47
    • 3543036376 scopus 로고    scopus 로고
    • Confocal microscopy analysis of native, full length and B-domain deleted coagulation factor VIII trafficking in mammalian cells
    • Becker S, Simpson JC, Pepperkok R et al. Confocal microscopy analysis of native, full length and B-domain deleted coagulation factor VIII trafficking in mammalian cells. Thromb. Haemost. 92(1), 23-35 (2004).
    • (2004) Thromb. Haemost. , vol.92 , Issue.1 , pp. 23-35
    • Becker, S.1    Simpson, J.C.2    Pepperkok, R.3
  • 48
    • 0022909287 scopus 로고
    • Construction and characterization of an active factor VIII variant lacking the central one-third of the molecule
    • Eaton DL, Wood WI, Eaton D et al. Construction and characterization of an active factor VIII variant lacking the central one-third of the molecule. Biochemistry 25(26), 8343-8347 (1986).
    • (1986) Biochemistry , vol.25 , Issue.26 , pp. 8343-8347
    • Eaton, D.L.1    Wood, W.I.2    Eaton, D.3
  • 49
    • 0022760260 scopus 로고
    • A large region (approximately equal to 95 kDa) of human factor VIII is dispensable for in vitro procoagulant activity
    • Toole JJ, Pittman DD, Orr EC, Murtha P, Wasley LC, Kaufman RJ. A large region (approximately equal to 95 kDa) of human factor VIII is dispensable for in vitro procoagulant activity. Proc. Natl Acad. Sci. USA 83(16), 5939-5942 (1986).
    • (1986) Proc. Natl Acad. Sci. USA , vol.83 , Issue.16 , pp. 5939-5942
    • Toole, J.J.1    Pittman, D.D.2    Orr, E.C.3    Murtha, P.4    Wasley, L.C.5    Kaufman, R.J.6
  • 50
    • 0027319588 scopus 로고
    • Biochemical, immunological, and in vivo functional characterization of B-domaindeleted factor VIII
    • Pittman DD, Alderman EM, Tomkinson KN, Wang JH, Giles AR, Kaufman RJ. Biochemical, immunological, and in vivo functional characterization of B-domaindeleted factor VIII. Blood 81(11), 2925-2935 (1993).
    • (1993) Blood , vol.81 , Issue.11 , pp. 2925-2935
    • Pittman, D.D.1    Alderman, E.M.2    Tomkinson, K.N.3    Wang, J.H.4    Giles, A.R.5    Kaufman, R.J.6
  • 51
    • 0034905074 scopus 로고    scopus 로고
    • A factor VIII minigene comprising the truncated intron i of factor IX highly improves the in vitro production of factor VIII
    • Plantier JL, Rodriguez MH, Enjolras N, Attali O, Negrier C. A factor VIII minigene comprising the truncated intron I of factor IX highly improves the in vitro production of factor VIII. Thromb. Haemost. 86(2), 596-603 (2001).
    • (2001) Thromb. Haemost. , vol.86 , Issue.2 , pp. 596-603
    • Plantier, J.L.1    Rodriguez, M.H.2    Enjolras, N.3    Attali, O.4    Negrier, C.5
  • 52
    • 0030821993 scopus 로고    scopus 로고
    • Mutagenesis of a potential immunoglobulin-binding protein-binding site enhances secretion of coagulation factor VIII
    • Swaroop M, Moussalli M, Pipe SW, Kaufman RJ. Mutagenesis of a potential immunoglobulin-binding protein-binding site enhances secretion of coagulation factor VIII. J. Biol. Chem. 272(39), 24121-24124 (1997).
    • (1997) J. Biol. Chem. , vol.272 , Issue.39 , pp. 24121-24124
    • Swaroop, M.1    Moussalli, M.2    Pipe, S.W.3    Kaufman, R.J.4
  • 54
    • 1342282981 scopus 로고    scopus 로고
    • Identification of porcine coagulation factor VIII domains responsible for high level expression via enhanced secretion
    • Doering CB, Healey JF, Parker ET, Barrow RT, Lollar P. Identification of porcine coagulation factor VIII domains responsible for high level expression via enhanced secretion. J. Biol. Chem. 279(8), 6546-6552 (2004).
    • (2004) J. Biol. Chem. , vol.279 , Issue.8 , pp. 6546-6552
    • Doering, C.B.1    Healey, J.F.2    Parker, E.T.3    Barrow, R.T.4    Lollar, P.5
  • 55
    • 0033505104 scopus 로고    scopus 로고
    • Autologous hematopoietic stem cell transplantation in refractory rheumatoid arthritis: Sustained response in two of four patients
    • Burt RK, Georganas C, Schroeder J et al. Autologous hematopoietic stem cell transplantation in refractory rheumatoid arthritis: sustained response in two of four patients. Arthritis Rheum. 42(11), 2281-2285 (1999).
    • (1999) Arthritis Rheum. , vol.42 , Issue.11 , pp. 2281-2285
    • Burt, R.K.1    Georganas, C.2    Schroeder, J.3
  • 56
    • 0037372443 scopus 로고    scopus 로고
    • High-dose immune suppression and autologous hematopoietic stem cell transplantation in refractory Crohn's disease
    • Burt RK, Traynor A, Oyama Y, Craig R. High-dose immune suppression and autologous hematopoietic stem cell transplantation in refractory Crohn's disease. Blood 101(5), 2064-2066 (2003).
    • (2003) Blood , vol.101 , Issue.5 , pp. 2064-2066
    • Burt, R.K.1    Traynor, A.2    Oyama, Y.3    Craig, R.4
  • 57
    • 0030667512 scopus 로고    scopus 로고
    • Hematopoietic stem-cell transplantation for systemic lupus erythematosus
    • Burt RK, Traynor A, Ramsey-Goldman R. Hematopoietic stem-cell transplantation for systemic lupus erythematosus. N. Engl. J. Med. 337(24), 1777-1778 (1997).
    • (1997) N. Engl. J. Med. , vol.337 , Issue.24 , pp. 1777-1778
    • Burt, R.K.1    Traynor, A.2    Ramsey-Goldman, R.3
  • 58
    • 32044473487 scopus 로고    scopus 로고
    • Nonmyeloablative hematopoietic stem cell transplantation for systemic lupus erythematosus
    • Burt RK, Traynor A, Statkute L et al. Nonmyeloablative hematopoietic stem cell transplantation for systemic lupus erythematosus. JAMA 295(5), 527-535 (2006).
    • (2006) JAMA , vol.295 , Issue.5 , pp. 527-535
    • Burt, R.K.1    Traynor, A.2    Statkute, L.3
  • 59
    • 0031907910 scopus 로고    scopus 로고
    • T cell-depleted autologous hematopoietic stem cell transplantation for multiple sclerosis: Report on the first three patients
    • Burt RK, Traynor AE, Cohen B et al. T cell-depleted autologous hematopoietic stem cell transplantation for multiple sclerosis: report on the first three patients. Bone Marrow Transplant. 21(6), 537-541 (1998).
    • (1998) Bone Marrow Transplant. , vol.21 , Issue.6 , pp. 537-541
    • Burt, R.K.1    Traynor, A.E.2    Cohen, B.3
  • 60
    • 33646585786 scopus 로고    scopus 로고
    • High-level expression of porcine factor VIII from genetically modified bone marrow-derived stem cells
    • Gangadharan B, Parker ET, Ide LM, Spencer HT, Doering CB. High-level expression of porcine factor VIII from genetically modified bone marrow-derived stem cells. Blood 107(10), 3859-3864 (2006).
    • (2006) Blood , vol.107 , Issue.10 , pp. 3859-3864
    • Gangadharan, B.1    Parker, E.T.2    Ide, L.M.3    Spencer, H.T.4    Doering, C.B.5
  • 61
    • 34249737517 scopus 로고    scopus 로고
    • Hematopoietic stem cells encoding porcine factor VIII induce pro-coagulant activity in hemophilia A mice with pre-existing factor VIII immunity
    • Doering CB, Gangadharan B, Dukart HZ, Spencer HT. Hematopoietic stem cells encoding porcine factor VIII induce pro-coagulant activity in hemophilia A mice with pre-existing factor VIII immunity. Mol. Ther. 15(6), 1093-1099 (2007).
    • (2007) Mol. Ther. , vol.15 , Issue.6 , pp. 1093-1099
    • Doering, C.B.1    Gangadharan, B.2    Dukart, H.Z.3    Spencer, H.T.4
  • 62
    • 35349015845 scopus 로고    scopus 로고
    • Hematopoietic stem-cell gene therapy of hemophilia A incorporating a porcine factor VIII transgene and nonmyeloablative conditioning regimens
    • Ide LM, Gangadharan B, Chiang KY, Doering CB, Spencer HT. Hematopoietic stem-cell gene therapy of hemophilia A incorporating a porcine factor VIII transgene and nonmyeloablative conditioning regimens. Blood 110(8), 2855-2863 (2007).
    • (2007) Blood , vol.110 , Issue.8 , pp. 2855-2863
    • Ide, L.M.1    Gangadharan, B.2    Chiang, K.Y.3    Doering, C.B.4    Spencer, H.T.5
  • 63
    • 7044284791 scopus 로고    scopus 로고
    • Sustained phenotypic correction of hemophilia A mice following oncoretroviral-mediated expression of a bioengineered human factor VIII gene in long-term hematopoietic repopulating cells
    • Moayeri M, Ramezani A, Morgan RA, Hawley TS, Hawley RG. Sustained phenotypic correction of hemophilia A mice following oncoretroviral-mediated expression of a bioengineered human factor VIII gene in long-term hematopoietic repopulating cells. Mol. Ther. 10(5), 892-902 (2004).
    • (2004) Mol. Ther. , vol.10 , Issue.5 , pp. 892-902
    • Moayeri, M.1    Ramezani, A.2    Morgan, R.A.3    Hawley, T.S.4    Hawley, R.G.5
  • 64
    • 0037097841 scopus 로고    scopus 로고
    • Induction of T-cell tolerance to an MHC class I alloantigen by gene therapy
    • DOI 10.1182/blood.V99.12.4394
    • Bagley J, Tian C, Sachs DH, Iacomini J. Induction of T-cell tolerance to an MHC class I alloantigen by gene therapy. Blood 99(12), 4394-4399 (2002). (Pubitemid 34627206)
    • (2002) Blood , vol.99 , Issue.12 , pp. 4394-4399
    • Bagley, J.1    Tian, C.2    Sachs, D.H.3    Lacomini, J.4
  • 65
    • 28844477590 scopus 로고    scopus 로고
    • Bone marrow transplantation combined with gene therapy to induce antigen-specific tolerance and ameliorate EAE
    • Xu B, Haviernik P, Wolfraim LA, Bunting KD, Scott DW. Bone marrow transplantation combined with gene therapy to induce antigen-specific tolerance and ameliorate EAE. Mol. Ther. 13(1), 42-48 (2006).
    • (2006) Mol. Ther. , vol.13 , Issue.1 , pp. 42-48
    • Xu, B.1    Haviernik, P.2    Wolfraim, L.A.3    Bunting, K.D.4    Scott, D.W.5
  • 66
    • 0034330694 scopus 로고    scopus 로고
    • Induction of B-cell tolerance by retroviral gene therapy
    • Bracy JL, Iacomini J. Induction of B-cell tolerance by retroviral gene therapy. Blood 96(9), 3008-3015 (2000).
    • (2000) Blood , vol.96 , Issue.9 , pp. 3008-3015
    • Bracy, J.L.1    Iacomini, J.2
  • 67
    • 28444459497 scopus 로고    scopus 로고
    • Correction of murine hemophilia A by hematopoietic stem cell gene therapy
    • Moayeri M, Hawley TS, Hawley RG. Correction of murine hemophilia A by hematopoietic stem cell gene therapy. Mol. Ther. 12(6), 1034-1042 (2005).
    • (2005) Mol. Ther. , vol.12 , Issue.6 , pp. 1034-1042
    • Moayeri, M.1    Hawley, T.S.2    Hawley, R.G.3
  • 68
    • 67649840877 scopus 로고    scopus 로고
    • Directed engineering of a high-expression chimeric transgene as a strategy for gene therapy of hemophilia A
    • Doering CB, Denning G, Dooriss K et al. Directed engineering of a high-expression chimeric transgene as a strategy for gene therapy of hemophilia A. Mol. Ther. 17(7), 1145-1154 (2009).
    • (2009) Mol. Ther. , vol.17 , Issue.7 , pp. 1145-1154
    • Doering, C.B.1    Denning, G.2    Dooriss, K.3
  • 69
    • 73349111285 scopus 로고    scopus 로고
    • Anti-CD3 antibodies modulate anti-factor VIII immune responses in hemophilia A mice after factor VIII plasmid-mediated gene therapy
    • Peng B, Ye P, Rawlings DJ, Ochs HD, Miao CH. Anti-CD3 antibodies modulate anti-factor VIII immune responses in hemophilia A mice after factor VIII plasmid-mediated gene therapy. Blood 114, 4373-4382 (2009).
    • (2009) Blood , vol.114 , pp. 4373-4382
    • Peng, B.1    Ye, P.2    Rawlings, D.J.3    Ochs, H.D.4    Miao, C.H.5
  • 70
    • 52649172605 scopus 로고    scopus 로고
    • Transient blockade of the inducible costimulator pathway generates long-term tolerance to factor VIII after nonviral gene transfer into hemophilia A mice
    • Peng B, Ye P, Blazar BR et al. Transient blockade of the inducible costimulator pathway generates long-term tolerance to factor VIII after nonviral gene transfer into hemophilia A mice. Blood 112(5), 1662-1672 (2008).
    • (2008) Blood , vol.112 , Issue.5 , pp. 1662-1672
    • Peng, B.1    Ye, P.2    Blazar, B.R.3
  • 71
    • 77950384133 scopus 로고    scopus 로고
    • CD4+FOXP3+ regulatory T cells confer long-term regulation of factor VIII-specific immune responses in plasmid-mediated gene therapy treated hemophilia mice
    • Miao CH, Harmeling BR, Ziegler SF et al. CD4+FOXP3+ regulatory T cells confer long-term regulation of factor VIII-specific immune responses in plasmid-mediated gene therapy treated hemophilia mice. Blood 114(19), 4034-4044 (2009).
    • (2009) Blood , vol.114 , Issue.19 , pp. 4034-4044
    • Miao, C.H.1    Harmeling, B.R.2    Ziegler, S.F.3
  • 72
    • 70149086119 scopus 로고    scopus 로고
    • A murine model for induction of long-term immunologic tolerance to factor VIII does not require persistent detectable levels of plasma factor VIII and involves contributions from Foxp3+ T regulatory cells
    • Matsui H, Shibata M, Brown B et al. A murine model for induction of long-term immunologic tolerance to factor VIII does not require persistent detectable levels of plasma factor VIII and involves contributions from Foxp3+ T regulatory cells. Blood 114(3), 677-685 (2009).
    • (2009) Blood , vol.114 , Issue.3 , pp. 677-685
    • Matsui, H.1    Shibata, M.2    Brown, B.3
  • 73
    • 33845648448 scopus 로고    scopus 로고
    • Efficient expression of a transgene in platelets using simian immunodeficiency virus-based vector harboring glycoprotein Iba promoter: In vivo model for platelettargeting gene therapy
    • Ohmori T, Mimuro J, Takano K et al. Efficient expression of a transgene in platelets using simian immunodeficiency virus-based vector harboring glycoprotein Iba promoter: in vivo model for platelettargeting gene therapy. FASEB J. 20(9), 1522-1524 (2006).
    • (2006) FASEB J. , vol.20 , Issue.9 , pp. 1522-1524
    • Ohmori, T.1    Mimuro, J.2    Takano, K.3
  • 74
    • 10744231807 scopus 로고    scopus 로고
    • Factor VIII ectopically expressed in platelets: Efficacy in hemophilia A treatment
    • Yarovoi HV, Kufrin D, Eslin DE et al. Factor VIII ectopically expressed in platelets: efficacy in hemophilia A treatment. Blood 102(12), 4006-4013 (2003).
    • (2003) Blood , vol.102 , Issue.12 , pp. 4006-4013
    • Yarovoi, H.V.1    Kufrin, D.2    Eslin, D.E.3
  • 75
    • 20444417088 scopus 로고    scopus 로고
    • Intracellular interaction of von Willebrand factor and factor VIII depends on cellular context: Lessons from platelet-expressed factor VIII
    • Yarovoi H, Nurden AT, Montgomery RR, Nurden P, Poncz M. Intracellular interaction of von Willebrand factor and factor VIII depends on cellular context: lessons from platelet-expressed factor VIII. Blood 105(12), 4674-4676 (2005).
    • (2005) Blood , vol.105 , Issue.12 , pp. 4674-4676
    • Yarovoi, H.1    Nurden, A.T.2    Montgomery, R.R.3    Nurden, P.4    Poncz, M.5
  • 76
    • 33745864802 scopus 로고    scopus 로고
    • Factor VIII ectopically targeted to platelets is therapeutic in hemophilia A with high-titer inhibitory antibodies
    • Shi Q, Wilcox DA, Fahs SA et al. Factor VIII ectopically targeted to platelets is therapeutic in hemophilia A with high-titer inhibitory antibodies. J. Clin. Invest. 116(7), 1974-1982 (2006).
    • (2006) J. Clin. Invest. , vol.116 , Issue.7 , pp. 1974-1982
    • Shi, Q.1    Wilcox, D.A.2    Fahs, S.A.3
  • 77
    • 45549109031 scopus 로고    scopus 로고
    • Platelet-delivered factor VIII provides limited resistance to anti-factor VIII inhibitors
    • Gewirtz J, Thornton MA, Rauova L, Poncz M. Platelet-delivered factor VIII provides limited resistance to anti-factor VIII inhibitors. J. Thromb. Haemost. 6(7), 1160-1166 (2008).
    • (2008) J. Thromb. Haemost. , vol.6 , Issue.7 , pp. 1160-1166
    • Gewirtz, J.1    Thornton, M.A.2    Rauova, L.3    Poncz, M.4
  • 78
    • 44249085878 scopus 로고    scopus 로고
    • Safety and efficacy of gene transfer for Leber's congenital amaurosis
    • Maguire AM, Simonelli F, Pierce EA et al. Safety and efficacy of gene transfer for Leber's congenital amaurosis. N. Engl. J. Med. 358(21), 2240-2248 (2008).
    • (2008) N. Engl. J. Med. , vol.358 , Issue.21 , pp. 2240-2248
    • Maguire, A.M.1    Simonelli, F.2    Pierce, E.A.3
  • 79
    • 44249120315 scopus 로고    scopus 로고
    • Effect of gene therapy on visual function in Leber's congenital amaurosis
    • Bainbridge JW, Smith AJ, Barker SS et al. Effect of gene therapy on visual function in Leber's congenital amaurosis. N. Engl. J. Med. 358(21), 2231-2239 (2008).
    • (2008) N. Engl. J. Med. , vol.358 , Issue.21 , pp. 2231-2239
    • Bainbridge, J.W.1    Smith, A.J.2    Barker, S.S.3
  • 80
    • 20144386644 scopus 로고    scopus 로고
    • Phenotypic correction and long-term expression of factor VIII in hemophilic mice by immunotolerization and nonviral gene transfer using the Sleeping Beauty transposon system
    • Ohlfest JR, Frandsen JL, Fritz S et al. Phenotypic correction and long-term expression of factor VIII in hemophilic mice by immunotolerization and nonviral gene transfer using the Sleeping Beauty transposon system. Blood 105(7), 2691-2698 (2005).
    • (2005) Blood , vol.105 , Issue.7 , pp. 2691-2698
    • Ohlfest, J.R.1    Frandsen, J.L.2    Fritz, S.3
  • 81
    • 33645882508 scopus 로고    scopus 로고
    • Sustained fVIII expression and phenotypic correction of hemophilia A in neonatal mice using an endothelial-targeted sleeping beauty transposon
    • Liu L, Mah C, Fletcher BS. Sustained fVIII expression and phenotypic correction of hemophilia A in neonatal mice using an endothelial-targeted sleeping beauty transposon. Mol. Ther. 13(5), 1006-1015 (2006).
    • (2006) Mol. Ther. , vol.13 , Issue.5 , pp. 1006-1015
    • Liu, L.1    Mah, C.2    Fletcher, B.S.3
  • 82
    • 67349250885 scopus 로고    scopus 로고
    • Molecular evolution of a novel hyperactive Sleeping Beauty transposase enables robust stable gene transfer in vertebrates
    • Mates L, Chuah MK, Belay E et al. Molecular evolution of a novel hyperactive Sleeping Beauty transposase enables robust stable gene transfer in vertebrates. Nat. Genet. 41(6), 753-761 (2009).
    • (2009) Nat. Genet. , vol.41 , Issue.6 , pp. 753-761
    • Mates, L.1    Chuah, M.K.2    Belay, E.3
  • 83
    • 68849130485 scopus 로고    scopus 로고
    • Nanocapsule-delivered Sleeping Beauty mediates therapeutic factor VIII expression in liver sinusoidal endothelial cells of hemophilia A mice
    • Kren BT, Unger GM, Sjeklocha L et al. Nanocapsule-delivered Sleeping Beauty mediates therapeutic factor VIII expression in liver sinusoidal endothelial cells of hemophilia A mice. J. Clin. Invest. 119(7), 2086-2099 (2009).
    • (2009) J. Clin. Invest. , vol.119 , Issue.7 , pp. 2086-2099
    • Kren, B.T.1    Unger, G.M.2    Sjeklocha, L.3
  • 84
    • 0033538448 scopus 로고    scopus 로고
    • Expression of factor VIII by murine liver sinusoidal endothelial cells
    • Do H, Healey JF, Waller EK, Lollar P. Expression of factor VIII by murine liver sinusoidal endothelial cells. J. Biol. Chem. 274(28), 19587-19592 (1999).
    • (1999) J. Biol. Chem. , vol.274 , Issue.28 , pp. 19587-19592
    • Do, H.1    Healey, J.F.2    Waller, E.K.3    Lollar, P.4
  • 85
    • 0842264039 scopus 로고    scopus 로고
    • Total correction of hemophilia A mice with canine FVIII using an AAV 8 serotype
    • Sarkar R, Tetreault R, Gao G et al. Total correction of hemophilia A mice with canine FVIII using an AAV 8 serotype. Blood 103(4), 1253-1260 (2004).
    • (2004) Blood , vol.103 , Issue.4 , pp. 1253-1260
    • Sarkar, R.1    Tetreault, R.2    Gao, G.3
  • 86
    • 33645908797 scopus 로고    scopus 로고
    • Long-term efficacy of adeno-associated virus serotypes 8 and 9 in hemophilia A dogs and mice
    • Sarkar R, Mucci M, Addya S et al. Long-term efficacy of adeno-associated virus serotypes 8 and 9 in hemophilia A dogs and mice. Hum. Gene Ther. 17(4), 427-439 (2006).
    • (2006) Hum. Gene Ther. , vol.17 , Issue.4 , pp. 427-439
    • Sarkar, R.1    Mucci, M.2    Addya, S.3
  • 87
    • 33745606715 scopus 로고    scopus 로고
    • Multiyear therapeutic benefit of AAV serotypes 2, 6 and 8 delivering factor VIII to hemophilia A mice and dogs
    • Jiang H, Lillicrap D, Patarroyo-White S et al. Multiyear therapeutic benefit of AAV serotypes 2, 6 and 8 delivering factor VIII to hemophilia A mice and dogs. Blood 108(1), 107-115 (2006).
    • (2006) Blood , vol.108 , Issue.1 , pp. 107-115
    • Jiang, H.1    Lillicrap, D.2    Patarroyo-White, S.3
  • 88
    • 46249125272 scopus 로고    scopus 로고
    • Complete correction of hemophilia A with adenoassociated viral vectors containing a full-size expression cassette
    • Lu H, Chen L, Wang J et al. Complete correction of hemophilia A with adenoassociated viral vectors containing a full-size expression cassette. Hum. Gene Ther. 19(6), 648-654 (2008).
    • (2008) Hum. Gene Ther. , vol.19 , Issue.6 , pp. 648-654
    • Lu, H.1    Chen, L.2    Wang, J.3
  • 89
    • 61649128763 scopus 로고    scopus 로고
    • Enhanced factor VIII heavy chain for gene therapy of hemophilia A
    • Chen L, Lu H, Wang J et al. Enhanced factor VIII heavy chain for gene therapy of hemophilia A. Mol. Ther. 17(3), 417-424 (2009).
    • (2009) Mol. Ther. , vol.17 , Issue.3 , pp. 417-424
    • Chen, L.1    Lu, H.2    Wang, J.3
  • 90
    • 34548796475 scopus 로고    scopus 로고
    • The enhancing effects of the light chain on heavy chain secretion in split delivery of factor VIII gene
    • Chen L, Zhu F, Li J et al. The enhancing effects of the light chain on heavy chain secretion in split delivery of factor VIII gene. Mol. Ther. 15(10), 1856-1862 (2007).
    • (2007) Mol. Ther. , vol.15 , Issue.10 , pp. 1856-1862
    • Chen, L.1    Zhu, F.2    Li, J.3
  • 91
    • 59149093795 scopus 로고    scopus 로고
    • The treatment of hemophilia A: From protein replacement to AAV-mediated gene therapy
    • Youjin S, Jun Y. The treatment of hemophilia A: from protein replacement to AAV-mediated gene therapy. Biotechnol. Lett. 31(3), 321-328 (2009).
    • (2009) Biotechnol. Lett. , vol.31 , Issue.3 , pp. 321-328
    • Youjin, S.1    Jun, Y.2
  • 92
    • 35349027352 scopus 로고    scopus 로고
    • Immune responses to AAV in clinical trials
    • Mingozzi F, High KA. Immune responses to AAV in clinical trials. Curr. Gene Ther. 7(5), 316-324 (2007).
    • (2007) Curr. Gene Ther. , vol.7 , Issue.5 , pp. 316-324
    • Mingozzi, F.1    High, K.A.2
  • 93
    • 0037079740 scopus 로고    scopus 로고
    • Use of blood outgrowth endothelial cells for gene therapy for hemophilia A
    • Lin Y, Chang L, Solovey A, Healey JF, Lollar P, Hebbel RP. Use of blood outgrowth endothelial cells for gene therapy for hemophilia A. Blood 99(2), 457-462 (2002).
    • (2002) Blood , vol.99 , Issue.2 , pp. 457-462
    • Lin, Y.1    Chang, L.2    Solovey, A.3    Healey, J.F.4    Lollar, P.5    Hebbel, R.P.6
  • 94
    • 35348867348 scopus 로고    scopus 로고
    • Ex vivo gene therapy for hemophilia A that enhances safe delivery and sustained in vivo factor VIII expression from lentivirally engineered endothelial progenitors
    • Matsui H, Shibata M, Brown B et al. Ex vivo gene therapy for hemophilia A that enhances safe delivery and sustained in vivo factor VIII expression from lentivirally engineered endothelial progenitors. Stem Cells 25(10), 2660-2669 (2007).
    • (2007) Stem Cells , vol.25 , Issue.10 , pp. 2660-2669
    • Matsui, H.1    Shibata, M.2    Brown, B.3
  • 95
    • 63649133449 scopus 로고    scopus 로고
    • Trans-splicing into highly abundant albumin transcripts for production of therapeutic proteins in vivo
    • Wang J, Mansfield SG, Cote CA et al. Trans-splicing into highly abundant albumin transcripts for production of therapeutic proteins in vivo. Mol. Ther. 17(2), 343-351 (2009).
    • (2009) Mol. Ther. , vol.17 , Issue.2 , pp. 343-351
    • Wang, J.1    Mansfield, S.G.2    Cote, C.A.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.